DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,440,887 | -28.9% | 167,033 | -31.2% | 0.28% | -35.1% |
| Q2 2023 | $58,266,000 | -51.8% | 242,775 | -49.4% | 0.43% | -59.1% |
| Q1 2023 | $120,979,200 | +48.9% | 480,000 | +56.8% | 1.06% | +25.9% |
| Q4 2022 | $81,228,871 | +787.7% | 306,039 | +747.9% | 0.84% | +701.0% |
| Q2 2022 | $9,150,000 | +718.4% | 36,093 | +347.0% | 0.10% | +377.3% |
| Q1 2020 | $1,118,000 | -98.3% | 8,074 | -98.2% | 0.02% | -97.4% |
| Q2 2019 | $64,883,000 | -11.9% | 453,984 | -18.6% | 0.84% | -14.0% |
| Q1 2019 | $73,635,000 | +67.6% | 557,760 | +30.9% | 0.97% | +52.3% |
| Q4 2018 | $43,940,000 | +731.7% | 426,108 | +527.8% | 0.64% | +1352.3% |
| Q4 2016 | $5,283,000 | -6.3% | 67,870 | -5.7% | 0.04% | -15.4% |
| Q3 2016 | $5,641,000 | -87.9% | 71,965 | -84.4% | 0.05% | -88.2% |
| Q2 2016 | $46,730,000 | +762.7% | 462,676 | +693.3% | 0.44% | +656.9% |
| Q4 2015 | $5,417,000 | -7.5% | 58,323 | -15.2% | 0.06% | -15.9% |
| Q3 2015 | $5,859,000 | +649.2% | 68,762 | +652.8% | 0.07% | +1280.0% |
| Q2 2015 | $782,000 | -42.8% | 9,134 | -42.7% | 0.01% | -78.3% |
| Q4 2014 | $1,366,000 | -95.9% | 15,939 | -96.3% | 0.02% | -96.9% |
| Q2 2014 | $33,635,000 | -18.0% | 427,220 | -21.9% | 0.75% | -33.7% |
| Q1 2014 | $41,021,000 | +66.0% | 546,947 | +70.9% | 1.13% | +15.5% |
| Q4 2013 | $24,705,000 | – | 320,014 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |